10 August 2021

DNAe Group Holdings Limited v HMRC; (FTT)

David Yates QC appeared for DNAe Group Holdings Limited (“DNAe”) which succeeded in establishing that it qualified as an SME for R&D expenditure under s.1044 of the Corporation Tax Act 2009. DNAe specialised in R&D into point of care solutions for DNA gene sequencing detection. The key question in the case was whether DNAe’s parent company, EGL, which was part of the Genting group, was a venture capital company within the meaning of the Annex to Commission Recommendation (EC) No 2003/361. Having reviewed the earlier cases of Pyreos and Monitor Audio, the First-tier Tribunal concluded that EGL was a venture capital company and rejected the argument advanced by HMRC that the investment in DNAe had some ulterior strategic benefit for the Genting group.

The judgment can be read here.

Menu